Girish Dhall, Md

This early-stage study is testing whether combining two existing cancer drugs, cabozantinib and selumetinib, is safe and effective for shrinking painful and disfiguring tumors (plexiform neurofibromas) in people aged 16 and older with neurofibromatosis type 1 (NF1). The research …